Pharmaceutical Industry
LifestyleGen X drugmaker is coughing up millions for Paris Olympics sponsorship to show Gen Z and millennials it’s a cool place to work
By Prarthana PrakashJanuary 10, 2024
By Susanne Barton and BloombergJanuary 8, 2024
By Fiona Rutherford and BloombergJanuary 8, 2024
HealthEli Lilly cracks down on the use of weight loss drugs Mounjaro and Zepbound for ‘cosmetic’ reasons instead of for diabetes and obesity
By Alexa MikhailJanuary 4, 2024
HealthOzempic, Wegovy demand so strong Europe’s most valuable listed company plans ‘mega manufacturing facility’
By Ellie Harmsworth and BloombergDecember 24, 2023
HealthPharma will pay rebates in 2024 on 48 drugs whose prices rose more than inflation this year: ‘Let’s call this for what it is—it simply is a rip off’
By Amanda Seitz and The Associated PressDecember 15, 2023
By Emma Hinchliffe and Joey AbramsDecember 14, 2023
CommentaryClimate change is unleashing a tsunami of infectious diseases–and we have fewer and fewer drugs that can treat them
By Jayasree K. IyerDecember 11, 2023
PoliticsThe White House threatens to cancel the patents of taxpayer-funded drugs if they’re too expensive for patients to afford
By Amanda Seitz, Zeke Miller and The Associated PressDecember 7, 2023
NewslettersEli Lilly’s CFO explains why the company’s newest weight-loss drug Zepbound will cost 20% less than the current options
By Sheryl EstradaNovember 29, 2023
LeadershipHow the high-stakes world of Formula 1 racing inspired Sanofi CEO Paul Hudson to deliver more medicines
By Christiaan HetznerNovember 27, 2023
FinanceBiden administration is cracking down on pharmacy middlemen, but they’re so powerful it might be too late to help independent drugstores
By Arthur Allen and KFF Health NewsNovember 16, 2023
CommentaryOur changing climate is jeopardizing worker health and productivity. Companies need to adapt their operations
By Martine Ferland and Judy MonroeNovember 15, 2023
By Ryan HoggNovember 6, 2023
Most Popular
